Literature DB >> 28349238

Strong association of insulin-like growth factor 1 receptor expression with histologic grade, subtype, and HPV status in penile squamous cell carcinomas: a tissue microarray study of 112 cases.

Sheila F Faraj1, Nilda Gonzalez-Roibon1, Enrico Munari1, Rajni Sharma1, Arthur L Burnett2, Antonio L Cubilla3, George J Netto4,5, Alcides Chaux6.   

Abstract

Insulin-like growth factor-1 receptor (IGF1R) plays a key role in cell growth and transformation. It is overexpressed in several solid tumors. This study evaluates IGF1R immunoexpression in penile squamous cell carcinoma (SCC). Four tissue microarrays were built from formalin-fixed, paraffin-embedded blocks of 112 penile SCC from Paraguay. Membranous IGF1R expression was evaluated by immunohistochemistry using two different approaches. An H-score was calculated in each spot (stain intensity by extent), and a median score per tumor was obtained. The second approach consisted of a score similar to the scoring system that was used for evaluating HER2 immunoexpression. For each case, the highest category obtained at any spot was used for statistical analyses. IGF1R expression was compared by histologic subtype, grade, and human papillomavirus (HPV) status. Median H-score was 22.5. The distribution of IGF1R expression by HER2 approach was as follows: 0 in 33.0% cases, 1+ in 46.4%, 2+ in 14.3%, and 3+ in 6.2%. IGF1R H-scores were associated with basaloid and warty/basaloid subtypes (p = 0.0026) and higher grade (p = 0.00052). Although weaker when using the HER2 approach, the association of IGF1R expression with subtype (p = 0.015) and grade (p = 0.015) remained significant. Furthermore, there was an association between IGF1R expression by HER2 approach and HPV status (p = 0.012). IGF1R was expressed in about two thirds of penile SCC cases, showing a strong positive association with histologic grade, subtype, and HPV status. Considering that grade is a predictor of outcome IGF1R expression may have prognostic relevance and could point to a potential role for IGF1R inhibitors in treating penile SCC.

Entities:  

Keywords:  IGF1R; Penile carcinoma; Squamous cell carcinoma

Mesh:

Substances:

Year:  2017        PMID: 28349238     DOI: 10.1007/s00428-017-2110-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  27 in total

Review 1.  Advances in the pathology of penile carcinomas.

Authors:  Alcides Chaux; Antonio L Cubilla
Journal:  Hum Pathol       Date:  2012-06       Impact factor: 3.466

Review 2.  A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers.

Authors:  Robert L Camp; Veronique Neumeister; David L Rimm
Journal:  J Clin Oncol       Date:  2008-10-20       Impact factor: 44.544

3.  Clinical Notice for American Society of Clinical Oncology-College of American Pathologists guideline recommendations on ER/PgR and HER2 testing in breast cancer.

Authors:  M Elizabeth Hammond; Daniel F Hayes; Antonio C Wolff
Journal:  J Clin Oncol       Date:  2011-04-18       Impact factor: 44.544

Review 4.  Penile cancer: current therapy and future directions.

Authors:  G Sonpavde; L C Pagliaro; C Buonerba; T B Dorff; R J Lee; G Di Lorenzo
Journal:  Ann Oncol       Date:  2013-01-04       Impact factor: 32.976

Review 5.  Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review.

Authors:  Aimee R Kreimer; Gary M Clifford; Peter Boyle; Silvia Franceschi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

6.  The epidermal growth factor receptor is frequently overexpressed in penile squamous cell carcinomas: a tissue microarray and digital image analysis study of 112 cases.

Authors:  Alcides Chaux; Enrico Munari; Betina Katz; Rajni Sharma; Kristen Lecksell; Antonio L Cubilla; Arthur L Burnett; George J Netto
Journal:  Hum Pathol       Date:  2013-09-25       Impact factor: 3.466

7.  Expression of GRK2 and IGF1R in hepatocellular carcinoma: clinicopathological and prognostic significance.

Authors:  Song-Bai Lin; Li Zhou; Zhi-Yong Liang; Wei-Xun Zhou; Ye Jin
Journal:  J Clin Pathol       Date:  2017-02-15       Impact factor: 3.411

8.  mTOR signaling pathway in penile squamous cell carcinoma: pmTOR and peIF4E over expression correlate with aggressive tumor behavior.

Authors:  Carla Ferrandiz-Pulido; Emili Masferrer; Agustin Toll; Javier Hernandez-Losa; Sergio Mojal; Ramon M Pujol; Santiago Ramon y Cajal; Ines de Torres; Vicente Garcia-Patos
Journal:  J Urol       Date:  2013-06-11       Impact factor: 7.450

9.  Relationship between insulin-like growth factor-1 receptor and human papillomavirus in patients with oropharyngeal cancer.

Authors:  Fumihiko Matsumoto; Mitsuhisa Fujimaki; Shinichi Ohba; Masataka Kojima; Junkichi Yokoyama; Katsuhisa Ikeda
Journal:  Head Neck       Date:  2014-06-27       Impact factor: 3.147

10.  Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomas.

Authors:  Elzbieta Stankiewicz; David M Prowse; Mansum Ng; Jack Cuzick; David Mesher; Frances Hiscock; Yong-Jie Lu; Nicholas Watkin; Catherine Corbishley; Wayne Lam; Daniel M Berney
Journal:  PLoS One       Date:  2011-03-02       Impact factor: 3.240

View more
  3 in total

1.  Carcinoma of the urethra.

Authors:  Miao Zhang; Adebowale J Adeniran; Raghunandan Vikram; Pheroze Tamboli; Curtis Pettaway; Jolanta Bondaruk; Jinsong Liu; Keith Baggerly; Bogdan Czerniak
Journal:  Hum Pathol       Date:  2017-08-18       Impact factor: 3.466

2.  P16INK4a expression in patients with penile cancer.

Authors:  Vicenilma de Andrade Martins; Jaqueline Diniz Pinho; Antonio Augusto Lima Teixeira Júnior; Leudivan Ribeiro Nogueira; Fábio França Silva; Victor Eduardo Maulen; André Salim Khayat; José de Ribamar Rodrigues Calixto; Herikson Araújo Costa; Leandra Naira Zambelli Ramalho; Gyl Eanes Barros Silva
Journal:  PLoS One       Date:  2018-10-12       Impact factor: 3.240

3.  The Biomarker Potential of Caveolin-1 in Penile Cancer.

Authors:  Andrej Panic; Henning Reis; Alina Wittka; Christopher Darr; Boris Hadaschik; Verena Jendrossek; Diana Klein
Journal:  Front Oncol       Date:  2021-03-31       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.